Lactose (India) Limited (BOM:524202)

Market Cap	1.20B -44.0%
Revenue (ttm)	1.45B +23.1%
Net Income	48.28M -30.2%
EPS	3.85 -29.9%
Shares Out	12.59M
PE Ratio	24.67
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,186
Average Volume	12,245
Open	89.40
Previous Close	90.21
Day's Range	89.40 - 99.94
52-Week Range	84.27 - 136.70
Beta	0.25
RSI	45.08
Earnings Date	Feb 13, 2026

About Lactose (India)

Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India and internationally. The company offers lactose monohydrate; solid dosage forms comprising dry granulated, film, and lacquer coated tablets, as well as uncoated and blister packed solid dose forms; and liquid dosage forms. It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as w...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 140
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524202

Financial Performance

In fiscal year 2025, Lactose (India)'s revenue was 1.16 billion, an increase of 2.20% compared to the previous year's 1.14 billion. Earnings were 51.63 million, a decrease of -23.95%.